Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jan 2005

Vitale Marco, Pelusi Giuseppe, Taroni Beatrice, Gobbi Giuliana, Micheloni Cristina, Rezzani Rita, Donato Francesco, Wang Xinhui, Ferrone Soldano

Abstract excerpt

PURPOSE: To investigate TAP1, TAP2, and HLA class I antigen expression in primary ovarian carcinoma lesions and to assess the clinical significance of defects in the expression of these molecules. EXPERIMENTAL DESIGN: Fifty-one formalin-fixed, paraffin-embedded primary ovarian carcinoma lesions were stained with affinity-purified rabbit anti-TAP1 and anti-TAP2 antibodies and with anti-HLA class I heavy chain...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antigen Presentation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Antigens, Neoplasm

Share to Down-Regulation

Share to Epithelial Cells

Share to Histocompatibility Antigens Class I

Share to Multivariate Analysis

Source

Identifiers

PMID: 15671529

Genes

TAP1
TAP2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.PMID 15671529Read ↗

Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer.Semantic proximity Read ↗

Transporter Associated with Antigen ProcessingProteins (TAP-1 and TAP-2) Gene Expressionof MHC-I Downregulated in Oral SquamousCarcinomaSemantic proximity Read ↗

Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma.Semantic proximity Read ↗

Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression.Semantic proximity Read ↗

Transporter associated with antigen processing 1 (TAP1) expression and prognostic analysis in breast, lung, liver, and ovarian cancer.Semantic proximity Read ↗

Mutations in TAP genes are common in cervical carcinomas.Semantic proximity Read ↗

MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.Semantic proximity Read ↗

Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: β2‐microglobulin inactivation in MSI‐positive tumors and LMP7/TAP2 downregulation in MSI‐negative tumorsSemantic proximity Read ↗

Loss of expression of antigen-presenting molecules in human pancreatic cancer and pancreatic cancer cell lines.Semantic proximity Read ↗

Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.Semantic proximity Read ↗

Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma.Semantic proximity Read ↗

Identification of mechanisms underlying transporter associated with antigen processing deficiency in metastatic murine carcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.